The American Chamber of Commerce in the Czech Republic is a non-profit, nongovernment organization governed independently by a board of directors elected from and by its membership. We are a member of the US Chamber of Commerce and the European Council of American Chambers of Commerce (ECACC). We connect more than 1600 top executives and company owners representing around 400 companies. Our member network spans industries, sizes and nationalities.
Our objective is to improve business environment in the Czech Republic. We can achieve it through networks of our members, business associations, public administration and NGOs we cooperate with. Our members can take an advantage of provided business opportunities, management improvements and advocacy.
AmCham: the Community of Next
Objectives of Our Community
We aim to make the Czech Republic the best place to do business in Europe by constantly improving the networks between businesses, the knowledge of managing a business, and policy governing business.
We pursue the next initiative that benefits both the wider business community and Czech society.
We strive to create the next business opportunity, whether it is a transaction, an investment, or a new government policy.
We cooperate with governments on the next reform that makes economic policy more transparent, fair, and prosperous for the country.
We share the expertise and experiences of our community to raise the standards of operational excellence.
Contact
Address: Dušní 10, 110 00 Prague 1
Phone: (420) 222-329-430
Fax: (420)222-329-433
E-mail: amcham@amcham.cz
The latest pharma news from Central and Eastern Europe (CEE), including a new report on the disparities between the region’s healthcare systems and those of Western Europe; why US companies…
Roman Grunt, CEO of Quinta Analytica, gives us an overview of the activities of how the Czech firm has managed to attract customers across the country and beyond by positioning…
PharmaBoardroom’s latest report: Healthcare & Life Sciences Review: Czech Republic is available for download now. Home to a USD 3.38 billion pharma market, one of Central and Eastern Europe’s…
Key stakeholders within the Czech medtech industry highlight how medical devices can improve efficiency and quality of care across the country’s healthcare landscape, why greater levels of collaboration are of…
Roman Samiec, general manager of Thuasne Czech Republic, introduces the company as a key competitor in the medical devices field, with their niche products addressing the unmet medical need in…
Miroslav Palát, president of CzechMed, the medical device association in the Czech Republic, and Jiří Pavlíček, who combines the responsibility of Chairman of the association and CEO of the medtech…
Pavla Nevolová, country head of EastHORN in the Czech Republic, shares the historical roots of the now multinational Czech CRO. Nevolová also shares her insights into the recent evolution of…
The Czech Republic boasts a solid clinical research infrastructure and a supportive regulatory environment, meaning that it stands out as one of Central and Eastern Europe’s top destinations for clinical…
In 1996 Jiří Žák, chairman & current CEO of FARMAK, borrowed half a billion Czech crowns to take over a state-owned producer of vitamins for which he had started working…
As one of the few pharma companies in the Czech Republic to offer products across the whole healthcare spectrum, including prescription drugs, generics, over-the-counter (OTC) treatments, and food supplements, the…
Roman Dusil, GM of Pierre Fabre Laboratories in the Czech Republic and Slovakia, shares how the Czech affiliate is ahead of Pierre Fabre’s global transformation of the convergence between the dermo-cosmetic…
Pharma industry stakeholders are generally quick to suggest that the Czech Republic is one of the most over-regulated markets in Europe, with new or innovative therapies facing significant delays before…
See our Cookie Privacy Policy Here
